Human Protein Z as the Second Known Heme-Binding Protein from the Endogenous Blood Coagulation Inhibitor System

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Protein Z (PZ) is a vitamin-K-dependent glycoprotein involved in anticoagulation.
• PZ shares homology with activated protein C (APC), another anticoagulant protein known to interact with heme.
• The role of coagulation inhibitors in heme-triggered effects remains largely unknown.

Purpose of the Study:

• To investigate the interaction between Protein Z and heme.
• To identify potential heme-binding sites in Protein Z.
• To determine the functional consequences of PZ-heme interaction on PZ's anticoagulant activity.

Main Methods:

• In silico studies and PZ-derived peptides were used to identify heme-binding sites.
• Protein-level binding studies were conducted to characterize PZ-heme interaction.
• Activated partial thromboplastin time (aPTT) assays were used to assess anticoagulant function in the presence of heme.

Main Results:

• A specific heme-binding site in Protein Z was identified, with binding characteristics similar to APC.
• Heme binding increased PZ's inhibitory effect on thrombin.
• Heme dampened PZ's anticoagulant function in aPTT assays, suggesting a prothrombotic tendency.

Conclusions:

• Protein Z directly interacts with heme, influencing its function.
• Heme binding to PZ has dual effects: enhancing thrombin inhibition and reducing anticoagulation.
• These findings highlight a potential prothrombotic role for PZ in heme-exposed conditions and warrant further investigation into heme's effects on blood coagulation.